Mutational analysis of the role of ADP-ribosylation activity and G(M1)-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin

European Journal of Immunology

Volumn 28, Issue 4, 1998, Pages 1243-1250

  De Haan, Lolke ^a   Feil, Ingeborg K ^b   Verweij, Willem R ^a   Holtrop, Marijke ^a   Hol, Wim G J ^b   Agsteribbe, Etienne ^a   Wilschut, Jan ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cholera toxin; IgA antibody; Mucosa

Indexed keywords

ANTIGEN; ENTEROTOXIN; GANGLIOSIDE GM1; IMMUNOLOGICAL ADJUVANT; INFLUENZA VIRUS HEMAGGLUTININ; KEYHOLE LIMPET HEMOCYANIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE MUTATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031979999     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199804)28:04<1243::AID-IMMU1243>3.0.CO;2-E     Document Type: Article

References (40)

1. Kuper, C. F., Koornstra, P. J., Hameleers, D. M. H., Biewenga, J., Spit, B. J., Duijvestijn, A. M., Van Breda Vriesman, P. J. C. and Sminia, T., The role of nasopharyngeal tissue. Immunol. Today 1992. 13: 219-224.
2. McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasawa, M. and Kiyono, H., The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 1992. 10: 75-88.
3. Clements, J. D., Hartzog, N. M. and Lyon, F. L., Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 1988. 6: 269-277.
4. Elson, C. O. and Ealding, W., Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 1984. 132: 2736-2741.
5. Elson, C. O. and Ealding, W., Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 1984. 133: 2892-2897.
6. Lycke, N. and Holmgren, J., Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 1986. 59: 301-308.
7. Snider, D. P., The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Crit. Rev. Immunol. 1995. 15: 317-384.
8. Sears, C. L. and Kaper, J. B., Enteric bacterial toxins: mechanism of action and linkage to intestinal secretion. Microbiol. Rev. 1996. 60: 167-215.
9. Spangler, B. D., Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 1992. 56: 622-647.
10. McKenzie, S. J. and Halsey, J. F., Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J. Immunol. 1984. 133: 1818-1824.
11. Tamura, S.-I., Samegai, Y., Kurata, H., Nagamine, T., Aizawa, C. and Kurata, T., Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 1988. 6: 409-415.
12. Czerkinsky, C., Russel, M. W., Lycke, N., Lindblad, M. and Holmgren, J., Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extra-mucosal tissues. Infect. Immun. 1989. 57: 1072-1077.
13. Vadolas, J., Davies, J. K., Wright, P. J. and Strugnell, R. A., Intranasal immunization with liposomes induces strong mucosal immune responses in mice. Eur. J. Immunol. 1995. 25: 969-975.
14. Lycke, N., Tsuji, T. and Holmgren, J., The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 1992. 22: 2277-2281.
15. Tamura, S.-I., Asanuma, H., Tomita, T., Komase, K., Kawahara, K., Danbara, H., Hattori, N., Watanabe, K., Suzuki, Y., Nagamine, T., Aizawa, C., Oya, A. and Kurata, T., Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Vaccine 1994. 12: 1083-1089.
16. Hazama, M., Mayumi-Aono, A., Miyazaki, T., Hinuma, S. and Fujisawa, Y., Intranasal immunization against herpes simplex virus by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2. Immunology 1993. 78: 643-649.
17. Dickinson, B. L. and Clements, J. D., Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 1995. 63: 1617-1623.
18. Di Tommaso, A., Saletti, G., Pizza, M., Rappuoli, R., Dougan, G., Abrignani, S., Douce, G. and De Magistris, M. T., Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 1996. 64: 974-979.
19. Douce, G., Turcotte, C., Cropley, I., Roberts, M., Pizza, M., Domenghini, M., Rappuoli, R. and Dougan, G., Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. USA 1995. 92: 1644-1648.
20. Giannelli, V., Fontana, M. R., Giuliani, M. M., Guangcai, D., Rappuoli, R. and Pizza, M., Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loop. Infect. Immun. 1997. 65: 331-334.
21. Verweij, W. R., DeHaan, L., Holtrop, M., Van Scharrenburg, G. J. M., Brands, R., Agsteribbe, E. and Wischut, J., Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza surface antigen. Vaccine, in press.
22. Wiley, D. C. and Skehel, J. J., The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Ann. Rev. Biochem. 1987. 56: 365-394.
23. De Haan, L., Verweij, W. R., Feil, I. K., Lijnema, T. H., Hol, W. G. J., Agsteribbe, E. and Wilschut, J., Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin. Infect. Immun. 1996. 64: 5413-5416.
24. Feil, I. K., Reddy, R., DeHaan, L., Merritt, E. A., VandenAkker, F., Storm, D. R. and Hol, W. G. J., Protein engineering studies of A-chain loop 47-56 of E. coli heat-labile enterotoxin point to a prominent role of this loop for cytotoxicity. Mol. Microbiol. 1996. 20: 823-832.
25. Soman, G., Narayanan, J., Martin, B. L. and Graves, D. J., Use of substituted (benzylidineamino)guanidines in the study of guanidino group specific ADP-ribosyltransferase. Biochemistry 1986. 25: 4113-4119.
26. Cieplak, W., Mead, D. J., Messer, R. J. and Grant, C. C. R., Site-directed mutagenic alteration of potential active-site residues of the A subunit of Escherichia coli heat-labile enterotoxin. J. Biol. Chem. 1995. 270: 30545-30550.
27. Moss, J., Stanley, S. J., Vaughan, M. and Tsuji, T., Interaction of ADP-ribosylation factor with Escherichia coli enterotoxin that contains an inactivating lysine 112 substitution. J. Biol. Chem. 1993. 268: 6383-6387.
28. Tsuji, T., Inoue, T., Miyama, A., Okamoto, K., Honda, T. and Miwatani, T., A single amino acid substitution in the A subunit of Escherichia coli enterotoxin results in loss of its toxic activity. J. Biol. Chem. 1990. 265: 22520-22525.
29. De Haan, L., Verweij, W. R., Holtrop, M., Feil, I. K., Hol, W. G. J., Agsteribbe, E. and Wilschut, J., Nontoxic variants of the Escherichia coli heat-labile enterotoxin as mucosal immunogens and adjuvants. STP Pharma Sciences, in press.
30. Douce, G., Fontana, M., Pizza, M., Rappuoli, R. and Dougan, G., Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infect. Immun. 1997. 65: 2821-2828.
31. Yamamoto, S., Takeda, Y., Yamamoto, M., Kurazono, H., Imaoka, K., Fujihashi, K., Noda, M., Kiyono, H. and McGhee, J. R., Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J. Exp. Med. 1997. 185: 1203-1210.
32. Anderson, D. L. and Tsoukas, C. D., Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway. J. Immunol. 1989. 143: 3647-3652.
33. Elson, C. O., Holland, S. P., Dertzbaugh, M. T., Cuff, C. F. and Anderson, A. O., Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J. Immunol. 1995. 154: 1032-1040.
34. M1 induces B cell activation. J. Immunol. 1992. 148: 1999-2005.
35. Nashar, T. O., Webb, H. M., Eaglestone, S., Williams, N. H. and Hirst, T. R., Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: Receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc. Natl. Acad. Sci. USA 1996. 93: 226-230.
36. Bromander, A., Holmgren, J. and Lycke, N., Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 1991. 146: 2908-2914.
37. Tamura, S.-I., Ishihira, K., Miyata, K., Aizawa, C. and Kurata, T., Mechanism of enhancement of the immune responses to influenza vaccine with cholera toxin B subunit and a trace amount of holotoxin. Vaccine 1995. 13: 339-341.
38. Gizurarson, S., Tamura, S.-I., Kurata, T., Hasiguchi, K. and Ogawa, H., The effect of cholera toxin and cholera toxin B subunit on the nasal mucosal membrane. Vaccine 1991. 9: 825-832.
39. Lycke, N., Karlsson, U., Sjölander, A. and Magnusson, K. E., The adjuvant effect of cholera toxin is associated with an increased intestinal permeability for luminal antigen. Scand. J. Immunol. 1991. 33: 691-696.
40. DeHaan, L., Verweij, W. R., Holtrop, M., Agsteribbe, E. and Wilschut, J., Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: Role of the A subunit. Vaccine 1996. 14: 620-626.